BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19679674)

  • 21. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model.
    Taguchi K; Hashimoto M; Ogaki S; Watanabe H; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
    J Pharm Sci; 2015 Sep; 104(9):3084-91. PubMed ID: 25755009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
    Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G
    J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of time interval between doses could eliminate accelerated blood clearance phenomenon induced by pegylated liposomal topotecan.
    Li C; Zhao X; Wang Y; Yang H; Li H; Li H; Tian W; Yang J; Cui J
    Int J Pharm; 2013 Feb; 443(1-2):17-25. PubMed ID: 23318366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
    Xu H; Ye F; Hu M; Yin P; Zhang W; Li Y; Yu X; Deng Y
    Drug Deliv; 2015; 22(5):598-607. PubMed ID: 24524364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production.
    Tagami T; Nakamura K; Shimizu T; Ishida T; Kiwada H
    J Control Release; 2009 Aug; 137(3):234-40. PubMed ID: 19361546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
    Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
    Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models.
    Conover CD; Linberg R; Shum KL; Shorr RG
    Artif Cells Blood Substit Immobil Biotechnol; 1999 Mar; 27(2):93-107. PubMed ID: 10092932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y; Shimizu T; Abu Lila AS; Ishida T; Kiwada H
    Biol Pharm Bull; 2015; 38(3):417-24. PubMed ID: 25757923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
    Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T; Ishida T; Kiwada H
    Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.
    Sakai H; Masada Y; Horinouchi H; Ikeda E; Sou K; Takeoka S; Suematsu M; Takaori M; Kobayashi K; Tsuchida E
    J Pharmacol Exp Ther; 2004 Dec; 311(3):874-84. PubMed ID: 15297471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.
    Tagami T; Nakamura K; Shimizu T; Yamazaki N; Ishida T; Kiwada H
    J Control Release; 2010 Mar; 142(2):160-6. PubMed ID: 19850094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
    Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats.
    Ma Y; Yang Q; Wang L; Zhou X; Zhao Y; Deng Y
    Eur J Pharm Sci; 2012 Apr; 45(5):539-45. PubMed ID: 22155543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
    Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles.
    Koide H; Asai T; Kato H; Ando H; Shiraishi K; Yokoyama M; Oku N
    Int J Pharm; 2012 Aug; 432(1-2):75-9. PubMed ID: 22562054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T; Abu Lila AS; Fujita R; Awata M; Kawanishi M; Hashimoto Y; Okuhira K; Ishima Y; Ishida T
    Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase.
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Yang H
    J Pharm Pharmacol; 2008 Dec; 60(12):1651-7. PubMed ID: 19000370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.
    Phillips WT; Klipper RW; Awasthi VD; Rudolph AS; Cliff R; Kwasiborski V; Goins BA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):665-70. PubMed ID: 9918573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.